The global interventional cardiology devices market will reach $11.2 billion by 2022, according to a report from Transparency Market Research.
Cardiologists use interventional cardiology devices to limit the need for major surgery on patients with heart valve disease, coronary artery disease and peripheral vascular disease. The devices use catheters inserted into blood vessels to carry out diagnostic tests or fix damaged heart structures. As the devices allow for minimally invasive procedures, they hold certain advantages such as reduced cost, minimal incision and shorter hospital stays and recovery times.
The report attributes the growth of the market to the rising rates of coronary artery disease, the increasing demand for minimally invasive surgeries, the increasing rate of obesity and the expanding geriatric population base. The development of new imaging technologies will also improve the diagnosis rate of percutaneous coronary interventions, further fueling market growth.
On the other hand, the lack of supportive reimbursement systems in some emerging economies and the slow rise in the number of percutaneous coronary interventions are the main factors hindering growth of the market.
More articles on supply chain:
Wisconsin lawmakers want answers over high drug costs
New gunshot wound device saves first life on battlefield
Needle-free drug delivery market predicted to reach $13B by 2023